Nitrase Therapeutics
Chemicals & Related Products · California, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
1000 Marina Blvd Ste 200, Brisbane, Cali...Website
www.nitrasetx.comRevenue
<$5 MillionIndustry
About Nitrase Therapeutics
Nitrase Therapeutics is focused on transforming the treatment of Parkinson's disease through its lead program, NDC-0524, a specially designed antibody targeting a modified form of the alpha-synuclein protein. This innovative treatment aims to slow the progression of Parkinson's disease, impacting the lives of over 10 million affected individuals worldwide. The company is pioneering a new class of enzymes known as nitrases, which are involved in various diseases. With strong preclinical efficacy and safety data, NDC-0524 is set to advance into Phase 1/2a clinical studies.Explore more
SIC Code 28,283NAICS Code 32,325Show moreNitrase Therapeutics Org Chart
Compare Similar Companies to Nitrase Therapeutics
Compare insights from companies similar to Nitrase Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Nitrase Therapeutics Tech Stack
A closer look at the technologies used by Nitrase Therapeutics
Top Chemicals & Related Products Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Nitrase Therapeutics
Sign Up For FreeTo access detailed company insights
Nitrase Therapeutics is focused on transforming the treatment of Parkinson's disease through its lead program, NDC-0524, a specially designed antibody targeting a modified form of the alpha-synuclein protein. This innovative treatment aims to slow the progression of Parkinson's disease, impacting the lives of over 10 million affected individuals wo... Read More